As an invaluable component of modern medicine, up to 80% of patients admitted in the US receive some form of infusion therapy . For patients receiving long term access, Catheter Related Bloodstream Infections (CRBSIs) can be a devastating and costly complication. In the US alone, it has been estimated that each year, 80,000 CRBSIs occur in ICU patients, costing approximately $2.3 billion to the US healthcare system . In addition, Medical Adhesive-Related Skin Injuries caused by recurring dressing changes continue to impact patients and can result in pain, delayed healing, and increased healthcare costs .
To address this problem, Covalon Technologies Ltd. has developed an innovative vascular access dressing that offers unparalleled infection prevention without sacrificing patient comfort. IV Clear incorporates dual antimicrobial action into a soft silicone adhesive, killing 99.99% of microorganisms commonly associated with CRBSIs and preventing regrowth for up to 7 days . No longer are clinicians required to compromise comfort over efficacy when choosing a product that fits within a hospital’s infection prevention bundle.
ONE MOTHER OF A CHILD WHO HAS A LONG-TERM CENTRAL VENOUS CATHETER SAID OF IV CLEAR™:
“Now that we’ve found IV Clear™, our son is no longer afraid of dressing changes. The skin around his catheter site is beautiful and healthy, easily visible through the dressing, and we no longer have to worry about missing a site infection or the fact that his dressing required frequent changes because it wasn’t lasting a full week. Thanks to IV Clear™, instead of worrying about his line, he is able to spend more of his time doing things typical kids do.”
In addition to IV Clear™, Covalon’s vascular access portfolio includes CovaView™ IV, a transparent film dressing that provides an effective barrier against external contaminants including fluid, bacteria, and yeast.